Content about Science and technology in Israel

May 14, 2013

Teva launches topotecan injection

Teva Health Systems has launched a generic injectable drug for small-cell lung cancer, the company said.

May 1, 2013

Teva introduces generic bronchospasm drug

Teva Pharmaceutical Industries has launched a generic inhaler used to treat bronchospasm, the company said.

April 8, 2013

Teva introduces generic painkiller

Teva Pharmaceutical Industries has launched a generic opioid medication for treating pain, the company said.

April 1, 2013

FDA approves new Teva contraceptive

The Food and Drug Administration has approved a new contraceptive therapy made by Teva Pharmaceutical Industries, Teva said Monday.

March 20, 2013

Teva appoints former Dyax executive

Teva Pharmaceutical Industries has appointed a former executive from Dyax to its executive team, the Israeli generic drug maker said.

March 12, 2013

Teva CFO to present at Barclays conference

Teva Pharmaceutical Industries will sponsor a live audio webcast at the 2013 Barclays Global Healthcare Conference on Thursday, the Israeli generic drug maker said Tuesday.

February 12, 2013

Teva appoints UCLA urologic oncology professor to board

Teva Pharmaceutical Industries has added a University of California at Los Angeles medical professor to its board of directors, the Israeli drug maker said.

December 28, 2012

Teva delays sales of Gilead generics pending court ruling

Teva Pharmaceuticals USA will delay the sales of generic versions of two Gilead Sciences HIV drugs until June 2013, the company stated.

December 21, 2012

Teva announces $1 billion debt refinancing

Teva Pharmaceutical Industries is buying $1 billion worth of its debt, the Israeli drug maker said.

December 12, 2012

Teva granted global license to experimental pain drug

Xenon Pharmaceuticals is licensing an experimental pain drug to Teva Pharmaceutical Industries in a deal worth up to $376 million, the companies said.

November 6, 2012

Teva appoints new president and CEO for North American generics business

Teva Pharmaceutical Industries has made a few new executive appointments, the drug maker said Tuesday.